Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6 | 93 | N/A | 8 | 106 |
| Receivables | 2,550 | 2,550 | N/A | N/A | N/A |
| TOTAL | $2,556 | $2,643 | $N/A | $8 | $106 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $2,556 | $2,643 | $N/A | $8 | $106 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 4,229 | 0 | 0 | 950 |
| Accrued Expenses | 203 | 171 | N/A | 103 | 79 |
| TOTAL | $203 | $4,400 | $N/A | $103 | $1,029 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,399 | 0 | 0 | 953 | 0 |
| TOTAL | $4,286 | $N/A | $N/A | $953 | $N/A |
| Total Liabilities | $4,489 | $4,400 | $N/A | $1,056 | $1,029 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,189 | N/A | N/A | 1,188 | 1,188 |
| Common Shares | 214 | 214 | N/A | 214 | 214 |
| Retained earnings | -16,039 | -15,777 | N/A | -12,008 | -11,790 |
| TOTAL | $-1,933 | $-1,757 | $N/A | $-1,048 | $-923 |
| Total Liabilities And Equity | $2,556 | $2,643 | $0 | $8 | $106 |